RCKT
Price
$6.93
Change
-$0.11 (-1.56%)
Updated
May 9, 02:04 PM (EDT)
Capitalization
715.46M
94 days until earnings call
RNA
Price
$28.52
Change
-$0.17 (-0.59%)
Updated
May 9, 02:37 PM (EDT)
Capitalization
3.15B
95 days until earnings call
Ad is loading...

RCKT vs RNA

Header iconRCKT vs RNA Comparison
Open Charts RCKT vs RNABanner chart's image
Rocket Pharmaceuticals
Price$6.93
Change-$0.11 (-1.56%)
Volume$1.67K
Capitalization715.46M
Avidity Biosciences
Price$28.52
Change-$0.17 (-0.59%)
Volume$200
Capitalization3.15B
RCKT vs RNA Comparison Chart
Loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCKT vs. RNA commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKT is a Hold and RNA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (RCKT: $7.04 vs. RNA: $28.69)
Brand notoriety: RCKT and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCKT: 93% vs. RNA: 140%
Market capitalization -- RCKT: $715.46M vs. RNA: $3.15B
RCKT [@Biotechnology] is valued at $715.46M. RNA’s [@Biotechnology] market capitalization is $3.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCKT’s FA Score shows that 1 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • RCKT’s FA Score: 1 green, 4 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than RCKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCKT’s TA Score shows that 5 TA indicator(s) are bullish while RNA’s TA Score has 4 bullish TA indicator(s).

  • RCKT’s TA Score: 5 bullish, 4 bearish.
  • RNA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than RNA.

Price Growth

RCKT (@Biotechnology) experienced а -10.43% price change this week, while RNA (@Biotechnology) price change was -12.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.90%. For the same industry, the average monthly price growth was +10.09%, and the average quarterly price growth was -13.91%.

Reported Earning Dates

RCKT is expected to report earnings on Aug 11, 2025.

RNA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-5.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.15B) has a higher market cap than RCKT($715M). RNA YTD gains are higher at: -1.341 vs. RCKT (-43.994). RCKT has higher annual earnings (EBITDA): -247.48M vs. RNA (-376.16M). RNA has more cash in the bank: 1.5B vs. RCKT (372M). RNA has less debt than RCKT: RNA (6.8M) vs RCKT (25.5M). RNA has higher revenues than RCKT: RNA (10.9M) vs RCKT (0).
RCKTRNARCKT / RNA
Capitalization715M3.15B23%
EBITDA-247.48M-376.16M66%
Gain YTD-43.994-1.3413,280%
P/E RatioN/AN/A-
Revenue010.9M-
Total Cash372M1.5B25%
Total Debt25.5M6.8M375%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCKTRNA
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNPFX63.400.14
+0.22%
American Funds New Perspective R5
ECLCX26.92N/A
N/A
Eaton Vance Growth C
OAKGX33.76N/A
N/A
Oakmark Global Investor
HLHIX26.97N/A
N/A
Virtus KAR Health Sciences Inst
MGHRX55.98N/A
N/A
Morgan Stanley Inst Growth IR